Sunil Krishnan, Vishal Rana, Nora A. Janjan, Gauri R. Varadhachary, James L. Abbruzzese, Prajnan Das, Marc E. Delclos, Morris S. Gould, Douglas B. Evans, Robert A. Wolff and Christopher H. Crane Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy Cancer 110
Version of Record online: 30 MAY 2007 | DOI: 10.1002/cncr.22735
The results from this study indicated that, by excluding patients who have rapid, distant disease progression, induction chemotherapy may select patients with locally advanced pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. The authors believe that this strategy of enriching the population of patients who receive a locoregional treatment modality merits prospective randomized evaluation.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field